Healthcare Realty Trust (HR) Q3 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q3 2025 earnings summary
8 Jul, 2026Executive summary
Strategic plan execution and portfolio repositioning drove improved results, with same-store NOI growth averaging 5.25%–5.4% over the last two quarters and occupancy up 180 basis points, supported by robust leasing and high tenant retention.
The company reported a GAAP net loss of $57.7 million ($0.17 per share) for Q3 2025, with NAREIT FFO at $0.34 per share, Normalized FFO at $0.41 per share, and FAD of $116.9 million (payout ratio 73%).
Disposed of 31 properties and two land parcels for $477.6 million, generating $447.3 million in net proceeds, with $700 million more under contract or LOI.
No new acquisitions occurred during the period; focus remains on core, high-growth MSAs and asset management.
Transition to an operations-oriented culture and asset management model is accelerating, enhancing accountability and performance.
Financial highlights
Normalized FFO per share rose to $0.41, up from $0.39 in Q3 2024; NAREIT FFO was $0.34 per share, and FAD was $116.9 million with a payout ratio of 73%.
Rental income for Q3 2025 was $287.4 million, down 6.2% year-over-year; net loss attributable to common stockholders was $57.7 million, improved from prior year.
Net debt to adjusted EBITDA fell to 5.8x, with further improvement expected as asset sales continue.
G&A expenses were $9.7 million for the quarter, with a 2026 target of $45 million.
Dividend declared for Q3 was $0.24 per share; $0.86 per share paid year-to-date.
Outlook and guidance
2025 guidance for Normalized FFO per share increased to $1.59–$1.61; same-store cash NOI growth guidance raised to 4.00%–4.75%.
G&A guidance set at $46 million–$49 million.
Margin improvement and occupancy gains expected to continue, with a 3-year growth framework targeting 65%–66% margins.
Management expects to meet liquidity needs through cash flows and a $1.4 billion undrawn credit facility.
Guidance does not include impacts from gains/losses on dispositions or impairments.
Latest events from Healthcare Realty Trust
- Exceeded 2025 FFO guidance, reduced leverage, and set disciplined 2026 growth targets.HR
Q4 20259 Jul 2026 - Q2 net loss on impairments, but strong leasing and asset sales support 2024 FFO outlook.HR
Q2 20248 Jul 2026 - Q1 2025 delivered stable FFO, improved net loss, and strong leasing amid ongoing risks.HR
Q1 202530 Jun 2026 - Record leasing, robust FFO growth, and focus on deleveraging set the stage for 2025.HR
Q4 202430 Jun 2026 - Record leasing and 6.9% NOI growth drove raised guidance and $100M in share repurchases.HR
Q1 20265 May 2026 - Strong NOI growth, high occupancy, and disciplined capital allocation drive sector leadership.HR
Investor presentation30 Apr 2026 - Director elections, auditor ratification, and say-on-pay headline the 2026 annual meeting.HR
Proxy filing7 Apr 2026 - Board recommends approval of director nominees, auditor, and executive compensation; strong ESG focus.HR
Proxy filing7 Apr 2026 - Normalized FFO per share rose 1.2% as leasing, asset sales, and share buybacks drove activity.HR
Q3 202417 Jan 2026